semaglutide patents Off-patent in 2026: the next revolution in anti-obesity medications The upcoming expiry of the

Reported problems encompass sensitivity to light, reduced or blurry vision, reversible and permanent compromised adaptation to darkness, reversible and permanent color perception changes, changes in refractive errors (temporary myopia), and alterations in the visual field, reversible post corneal refractive surgery complications like keratitis and opacities

Ask whether there are published studies, what outcomes were measured, and whether results apply to your condition

If patients experience persistent vomiting or inability to maintain adequate hydration while taking semaglutide, they should contact their healthcare provider promptly

Human studies vary in design, but several themes repeat